Literature DB >> 31212066

CARD9 inhibits mitochondria-dependent apoptosis of cardiomyocytes under oxidative stress via interacting with Apaf-1.

Yuanbin Li1, Pengfei Liang2, Bimei Jiang3, Yuting Tang1, Qinglan Lv1, Hong Hao4, Zhenguo Liu4, Xianzhong Xiao1.   

Abstract

Cardiomyocyte apoptosis is known to contribute to myocardial ischemia/reperfusion (I/R) injury. Caspase recruitment domain-containing protein 9 (CARD9) play a role in cardiac fibrosis and dysfunction. However, the role of CARD9 in apoptosis of cardiomyocytes in myocardial I/R injury and its underlying mechanisms are still unclear. In this study, CARD9 expression was found to increase in H9c2 cells in response to hydrogen peroxide. Loss of CARD9 significantly increased caspase-3 activation and cardiomyocyte death following oxidative stress in vitro. Conversely, CARD9 overexpression decreased apoptosis as evidenced by a reduction in caspase-3 activation and the apoptotic rate. The caspase recruitment domain (CARD) of CARD9 was necessary for the protective effect of CARD9 against oxidative stress in cardiomyocytes. CARD9 suppressed the activation of caspase-9 by interacting with Apaf-1 via its CARD domain in H9c2 cells exposed to H2O2. Ablation of caspase-9 activity by z-lehd-fmk effectively prevented the detrimental effect of CARD9 deficiency on cardiomyocytes. Wild-type (WT) and CARD9-/- mice were subjected to 30 min of left ascending coronary (LAD) ischemia and 12 h of reperfusion. TdT-mediated dUTP nick end labeling (TUNEL) staining analysis showed that CARD9-/- mice exhibited a significantly higher number of apoptotic-positive cells after myocardial I/R injury than the WT mice. These results suggest that CARD9 protects cardiomyocytes from apoptosis by interacting with Apaf-1 and interfering with apoptosome formation following myocardial I/R injury in vivo and in vitro.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Apaf-1; Apoptosis; CARD9; Caspase-9; Myocardial I/R injury; Oxidative stress

Year:  2019        PMID: 31212066     DOI: 10.1016/j.freeradbiomed.2019.06.017

Source DB:  PubMed          Journal:  Free Radic Biol Med        ISSN: 0891-5849            Impact factor:   7.376


  7 in total

1.  MIR22HG Aggravates Oxygen-Glucose Deprivation and Reoxygenation-Induced Cardiomyocyte Injury through the miR-9-3p/SH2B3 Axis.

Authors:  Yi Ge; Lishi Liu; Liang Luo; Yu Fang; Tong Ni
Journal:  Cardiovasc Ther       Date:  2022-05-31       Impact factor: 3.368

Review 2.  The roles of the inhibitory autophagy regulator Rubicon in the heart: A new therapeutic target to prevent cardiac cell death.

Authors:  Jihoon Nah; Daniela Zablocki; Junichi Sadoshima
Journal:  Exp Mol Med       Date:  2021-04-14       Impact factor: 8.718

Review 3.  CARD9 Regulation and its Role in Cardiovascular Diseases.

Authors:  Haina Zhang; Yeling Wang; Hongbo Men; Wenqian Zhou; Shanshan Zhou; Quan Liu; Lu Cai
Journal:  Int J Biol Sci       Date:  2022-01-01       Impact factor: 6.580

Review 4.  CARD9 Signaling, Inflammation, and Diseases.

Authors:  Xuanyou Liu; Bimei Jiang; Hong Hao; Zhenguo Liu
Journal:  Front Immunol       Date:  2022-03-30       Impact factor: 7.561

5.  lncRNA Oip5-as1 attenuates myocardial ischaemia/reperfusion injury by sponging miR-29a to activate the SIRT1/AMPK/PGC1α pathway.

Authors:  Xiaowei Niu; Shuangshuang Pu; Chun Ling; Jizhe Xu; Jing Wang; Shaobo Sun; Yali Yao; Zheng Zhang
Journal:  Cell Prolif       Date:  2020-05-28       Impact factor: 6.831

6.  Inflammasome Sensor NLRP1 Confers Acquired Drug Resistance to Temozolomide in Human Melanoma.

Authors:  Zili Zhai; Jenny Mae Samson; Takeshi Yamauchi; Prasanna K Vaddi; Yuko Matsumoto; Charles A Dinarello; Dinoop Ravindran Menon; Mayumi Fujita
Journal:  Cancers (Basel)       Date:  2020-09-04       Impact factor: 6.639

7.  PTB domain and leucine zipper motif 1 (APPL1) inhibits myocardial ischemia/hypoxia-reperfusion injury via inactivation of apoptotic protease activating factor-1 (APAF-1)/Caspase9 signaling pathway.

Authors:  Lina Bai; Junhua Yang; Hong Zhang; Wei Liao; Yunguang Cen
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.